80 related articles for article (PubMed ID: 3101313)
1. [Effect of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on scopolamine-induced impairment of short-term memory in rats].
Yamazaki N; Nagaoka A; Nagawa Y
Yakubutsu Seishin Kodo; 1986 Sep; 6(3):359-66. PubMed ID: 3101313
[TBL] [Abstract][Full Text] [Related]
2. [Effect of idebenone on scopolamine-induced impairment of short-term memory in rats].
Yamazaki N; Nagaoka A; Nagawa Y
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):321-8. PubMed ID: 3832686
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats.
Yamamura M; Kinoshita K; Nakagawa H; Ishida R
Jpn J Pharmacol; 1991 Feb; 55(2):241-53. PubMed ID: 1906119
[TBL] [Abstract][Full Text] [Related]
4. [Interaction with cholinergic drugs in reversal of cycloheximide-induced amnesia by thyrotropin-releasing hormone and its analog DN-1417 in mice].
Yamazaki N; Shintani M; Saji Y; Nagawa Y
Yakubutsu Seishin Kodo; 1983 Dec; 3(3):127-36. PubMed ID: 6431710
[TBL] [Abstract][Full Text] [Related]
5. Idebenone improves learning and memory impairment induced by cholinergic or serotonergic dysfunction in rats.
Yamazaki N; Nomura M; Nagaoka A; Nagawa Y
Arch Gerontol Geriatr; 1989 May; 8(3):225-39. PubMed ID: 2764640
[TBL] [Abstract][Full Text] [Related]
6. NS-3(CG3703), a TRH analog, ameliorates scopolamine-induced memory disruption in rats.
Ogasawara T; Nakagawa Y; Ukai Y; Tamura M; Kimura K
Pharmacol Biochem Behav; 1995 Aug; 51(4):929-34. PubMed ID: 7675879
[TBL] [Abstract][Full Text] [Related]
7. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
Yamamoto M; Ozawa Y; Takeuchi H
Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
[TBL] [Abstract][Full Text] [Related]
8. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
[TBL] [Abstract][Full Text] [Related]
9. [TRH and its analog (DN-1417). Effects on central dopaminergic system-dependent behaviors in rats and mice].
Miyamoto M; Saji Y; Nagawa Y
Nihon Yakurigaku Zasshi; 1985 Mar; 85(3):129-41. PubMed ID: 3924793
[TBL] [Abstract][Full Text] [Related]
10. Validation and scopolamine-reversal of latent learning in the water maze utilizing a revised direct platform placement procedure.
Malin DH; Schaar KL; Izygon JJ; Nghiem DM; Jabitta SY; Henceroth MM; Chang YH; Daggett JM; Ward CP
Pharmacol Biochem Behav; 2015 Aug; 135():90-6. PubMed ID: 26033423
[TBL] [Abstract][Full Text] [Related]
11. Effect of scopolamine and nootropic drugs on rewarded alternation in a T-maze.
Bartolini L; Risaliti R; Pepeu G
Pharmacol Biochem Behav; 1992 Dec; 43(4):1161-4. PubMed ID: 1475299
[TBL] [Abstract][Full Text] [Related]
12. Influence of age on cognition and scopolamine induced memory impairment in rats measured in the radial maze paradigm.
Appenroth D; Fleck C
Arzneimittelforschung; 2010; 60(6):293-8. PubMed ID: 20648917
[TBL] [Abstract][Full Text] [Related]
13. Hippocampal long term memory: effect of the cholinergic system on local protein synthesis.
Lana D; Cerbai F; Di Russo J; Boscaro F; Giannetti A; Petkova-Kirova P; Pugliese AM; Giovannini MG
Neurobiol Learn Mem; 2013 Nov; 106():246-57. PubMed ID: 24076274
[TBL] [Abstract][Full Text] [Related]
14. Estrogen and estrogen-progesterone treatments counteract the effect of scopolamine on reinforced T-maze alternation in female rats.
Dohanich GP; Fader AJ; Javorsky DJ
Behav Neurosci; 1994 Oct; 108(5):988-92. PubMed ID: 7826521
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of the ameliorating effect on short-term memory impairment and antinociceptive effect of KT-90 in mice.
Hiramatsu M; Hoshino T; Kanematsu K
Behav Brain Res; 2005 May; 160(2):374-81. PubMed ID: 15863234
[TBL] [Abstract][Full Text] [Related]
16. Agmatine protects against scopolamine-induced water maze performance impairment and hippocampal ERK and Akt inactivation.
Moosavi M; Khales GY; Abbasi L; Zarifkar A; Rastegar K
Neuropharmacology; 2012 Apr; 62(5-6):2018-23. PubMed ID: 22248637
[TBL] [Abstract][Full Text] [Related]
17. TRH attenuates scopolamine-induced memory impairment in humans.
Molchan SE; Mellow AM; Lawlor BA; Weingartner HJ; Cohen RM; Cohen MR; Sunderland T
Psychopharmacology (Berl); 1990; 100(1):84-9. PubMed ID: 2104988
[TBL] [Abstract][Full Text] [Related]
18. Memory deficits following internal capsule lesions in rats and their improvement by L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide (RGH-2202), a thyrotropin-releasing hormone analogue.
Oka M; Ito T; Furukawa K; Karasawa T; Kadokawa T
Arch Int Pharmacodyn Ther; 1990; 306():18-33. PubMed ID: 1981666
[TBL] [Abstract][Full Text] [Related]
19. Estrogen improves performance of reinforced T-maze alternation and prevents the amnestic effects of scopolamine administered systemically or intrahippocampally.
Fader AJ; Hendricson AW; Dohanich GP
Neurobiol Learn Mem; 1998 May; 69(3):225-40. PubMed ID: 9707487
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptors interact with the retrieval memory enhancing effect of pioglitazone in mice.
Almasi-Nasrabadi M; Gharedaghi MH; Rezazadeh P; Dehpour AR; Javadi-Paydar M
Pharmacol Biochem Behav; 2014 Nov; 126():136-45. PubMed ID: 25284130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
